Trial: 202011041

A Randomized Phase II Trial of Cabozantinib Combined with PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Phase

II

Principal Investigator

Van Tine, Brian

Disease Site

Soft Tissue

Learn more about this study at: clinicaltrials.gov